A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches.
Ezekwesiri Michael NwanosikeWendy SunterMuhammad Ayub AnsariHamid A MerchantBarbara R ConwaySyed Shahzad HasanPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
Data-driven approaches can identify key factors associated with clinical outcomes following the dosing of DOACs in morbidly obese patients. This will help design further studies to explore well tolerated and effective DOAC doses for morbidly obese patients.